Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectors

S. Crotty, Chris J Miller, B. L. Lohman, M. R. Neagu, L. Compton, D. Lu, F. X S Lu, L. Fritts, J. D. Lifson, R. Andino

Research output: Contribution to journalArticle

93 Citations (Scopus)

Abstract

Here we provide the first report of protection against a vaginal challenge with a highly virulent simian immunodeficiency virus (SIV) by using a vaccine vector. New poliovirus vectors based on Sabin 1 and 2 vaccine strain viruses were constructed, and these vectors were used to generate a series of new viruses containing SIV gag, pol, env, nef, and tat in overlapping fragments. Two cocktails of 20 transgenic polioviruses (SabRV1-SIV and SabRV2-SIV) were inoculated into seven cynomolgus macaques. All monkeys produced substantial anti-SIV serum and mucosal antibody responses. SIV-specific cytotoxic T-lymphocyte responses were detected in three of seven monkeys after vaccination. All 7 vaccinated macaques, as well as 12 control macaques, were challenged vaginally with pathogenic SIVmac251. Strikingly, four of the seven vaccinated animals exhibited substantial protection against the vaginal SIV challenge. All 12 control monkeys became SIV positive. In two of the seven SabRV-SIV-vaccinated monkeys we found no virological evidence of infection following challenge, indicating that these two monkeys were completely protected. Two additional SabRV-SIV-vaccinated monkeys exhibited a pronounced reduction in postacute viremia to <103 copies/ml, suggesting that the vaccine elicited an effective cellular immune response. Three of six control animals developed clinical AIDS by 48 weeks postchallenge. In contrast, all seven vaccinated monkeys remained healthy as judged by all clinical parameters. These results demonstrate the efficacy of SabRV as a potential human vaccine vector, and they show that the use of a vaccine vector cocktail expressing an array of defined antigenic sequences can be an effective vaccination strategy in an outbred population.

Original languageEnglish (US)
Pages (from-to)7435-7452
Number of pages18
JournalJournal of Virology
Volume75
Issue number16
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Simian immunodeficiency virus
Enterovirus C
Simian Immunodeficiency Virus
Poliovirus
Haplorhini
monkeys
vector vaccines
Vaccines
Macaca
Vaccination
vaccination
vaccines
Viruses
viruses
cytotoxic T-lymphocytes
Macaca fascicularis
Viremia
viremia
Cytotoxic T-Lymphocytes
Cellular Immunity

ASJC Scopus subject areas

  • Immunology

Cite this

Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectors. / Crotty, S.; Miller, Chris J; Lohman, B. L.; Neagu, M. R.; Compton, L.; Lu, D.; Lu, F. X S; Fritts, L.; Lifson, J. D.; Andino, R.

In: Journal of Virology, Vol. 75, No. 16, 2001, p. 7435-7452.

Research output: Contribution to journalArticle

Crotty, S, Miller, CJ, Lohman, BL, Neagu, MR, Compton, L, Lu, D, Lu, FXS, Fritts, L, Lifson, JD & Andino, R 2001, 'Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectors', Journal of Virology, vol. 75, no. 16, pp. 7435-7452. https://doi.org/10.1128/JVI.75.16.7435-7452.2001
Crotty, S. ; Miller, Chris J ; Lohman, B. L. ; Neagu, M. R. ; Compton, L. ; Lu, D. ; Lu, F. X S ; Fritts, L. ; Lifson, J. D. ; Andino, R. / Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectors. In: Journal of Virology. 2001 ; Vol. 75, No. 16. pp. 7435-7452.
@article{50e0829bac0947cfaa6331b30c7e5c13,
title = "Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectors",
abstract = "Here we provide the first report of protection against a vaginal challenge with a highly virulent simian immunodeficiency virus (SIV) by using a vaccine vector. New poliovirus vectors based on Sabin 1 and 2 vaccine strain viruses were constructed, and these vectors were used to generate a series of new viruses containing SIV gag, pol, env, nef, and tat in overlapping fragments. Two cocktails of 20 transgenic polioviruses (SabRV1-SIV and SabRV2-SIV) were inoculated into seven cynomolgus macaques. All monkeys produced substantial anti-SIV serum and mucosal antibody responses. SIV-specific cytotoxic T-lymphocyte responses were detected in three of seven monkeys after vaccination. All 7 vaccinated macaques, as well as 12 control macaques, were challenged vaginally with pathogenic SIVmac251. Strikingly, four of the seven vaccinated animals exhibited substantial protection against the vaginal SIV challenge. All 12 control monkeys became SIV positive. In two of the seven SabRV-SIV-vaccinated monkeys we found no virological evidence of infection following challenge, indicating that these two monkeys were completely protected. Two additional SabRV-SIV-vaccinated monkeys exhibited a pronounced reduction in postacute viremia to <103 copies/ml, suggesting that the vaccine elicited an effective cellular immune response. Three of six control animals developed clinical AIDS by 48 weeks postchallenge. In contrast, all seven vaccinated monkeys remained healthy as judged by all clinical parameters. These results demonstrate the efficacy of SabRV as a potential human vaccine vector, and they show that the use of a vaccine vector cocktail expressing an array of defined antigenic sequences can be an effective vaccination strategy in an outbred population.",
author = "S. Crotty and Miller, {Chris J} and Lohman, {B. L.} and Neagu, {M. R.} and L. Compton and D. Lu and Lu, {F. X S} and L. Fritts and Lifson, {J. D.} and R. Andino",
year = "2001",
doi = "10.1128/JVI.75.16.7435-7452.2001",
language = "English (US)",
volume = "75",
pages = "7435--7452",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "16",

}

TY - JOUR

T1 - Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectors

AU - Crotty, S.

AU - Miller, Chris J

AU - Lohman, B. L.

AU - Neagu, M. R.

AU - Compton, L.

AU - Lu, D.

AU - Lu, F. X S

AU - Fritts, L.

AU - Lifson, J. D.

AU - Andino, R.

PY - 2001

Y1 - 2001

N2 - Here we provide the first report of protection against a vaginal challenge with a highly virulent simian immunodeficiency virus (SIV) by using a vaccine vector. New poliovirus vectors based on Sabin 1 and 2 vaccine strain viruses were constructed, and these vectors were used to generate a series of new viruses containing SIV gag, pol, env, nef, and tat in overlapping fragments. Two cocktails of 20 transgenic polioviruses (SabRV1-SIV and SabRV2-SIV) were inoculated into seven cynomolgus macaques. All monkeys produced substantial anti-SIV serum and mucosal antibody responses. SIV-specific cytotoxic T-lymphocyte responses were detected in three of seven monkeys after vaccination. All 7 vaccinated macaques, as well as 12 control macaques, were challenged vaginally with pathogenic SIVmac251. Strikingly, four of the seven vaccinated animals exhibited substantial protection against the vaginal SIV challenge. All 12 control monkeys became SIV positive. In two of the seven SabRV-SIV-vaccinated monkeys we found no virological evidence of infection following challenge, indicating that these two monkeys were completely protected. Two additional SabRV-SIV-vaccinated monkeys exhibited a pronounced reduction in postacute viremia to <103 copies/ml, suggesting that the vaccine elicited an effective cellular immune response. Three of six control animals developed clinical AIDS by 48 weeks postchallenge. In contrast, all seven vaccinated monkeys remained healthy as judged by all clinical parameters. These results demonstrate the efficacy of SabRV as a potential human vaccine vector, and they show that the use of a vaccine vector cocktail expressing an array of defined antigenic sequences can be an effective vaccination strategy in an outbred population.

AB - Here we provide the first report of protection against a vaginal challenge with a highly virulent simian immunodeficiency virus (SIV) by using a vaccine vector. New poliovirus vectors based on Sabin 1 and 2 vaccine strain viruses were constructed, and these vectors were used to generate a series of new viruses containing SIV gag, pol, env, nef, and tat in overlapping fragments. Two cocktails of 20 transgenic polioviruses (SabRV1-SIV and SabRV2-SIV) were inoculated into seven cynomolgus macaques. All monkeys produced substantial anti-SIV serum and mucosal antibody responses. SIV-specific cytotoxic T-lymphocyte responses were detected in three of seven monkeys after vaccination. All 7 vaccinated macaques, as well as 12 control macaques, were challenged vaginally with pathogenic SIVmac251. Strikingly, four of the seven vaccinated animals exhibited substantial protection against the vaginal SIV challenge. All 12 control monkeys became SIV positive. In two of the seven SabRV-SIV-vaccinated monkeys we found no virological evidence of infection following challenge, indicating that these two monkeys were completely protected. Two additional SabRV-SIV-vaccinated monkeys exhibited a pronounced reduction in postacute viremia to <103 copies/ml, suggesting that the vaccine elicited an effective cellular immune response. Three of six control animals developed clinical AIDS by 48 weeks postchallenge. In contrast, all seven vaccinated monkeys remained healthy as judged by all clinical parameters. These results demonstrate the efficacy of SabRV as a potential human vaccine vector, and they show that the use of a vaccine vector cocktail expressing an array of defined antigenic sequences can be an effective vaccination strategy in an outbred population.

UR - http://www.scopus.com/inward/record.url?scp=0034910934&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034910934&partnerID=8YFLogxK

U2 - 10.1128/JVI.75.16.7435-7452.2001

DO - 10.1128/JVI.75.16.7435-7452.2001

M3 - Article

C2 - 11462016

AN - SCOPUS:0034910934

VL - 75

SP - 7435

EP - 7452

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 16

ER -